cdmo.directory
← Compare landing

CRAMSN vs Grifols Partnership

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cramsn-research-park/grifols

CategoryCRAMSNGrifols Partnership
Listed sitebothcdmo
SummaryCRAMSN is a contract research, development, and manufacturing organization (CRO/CDMO/CMO) offering end-to-end solutions for drug substance and drug product development with GMP-certified facilities recognized by US, EU, Japan, and Canada regulatory authorities.CDMO specializing in small molecule injectable products, including concentrated and diluted parenteral formulations and intravenous solutions, leveraging 100+ years of Grifols expertise.
Services
  • Process Development
  • CMC Analytical Development
  • Formulation Development
  • Technology Transfer
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Formulation Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • API Synthesis & Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Process Development
  • Small Molecule Development & Manufacturing
  • Quality Control Testing
  • CMC Analytical Development
ModalitiesData not yet provided.
  • Biologics (Other)
  • Small Molecule
IndicationsData not yet provided.
  • Immunology
  • Neurology
  • Cardiovascular
  • Infectious Disease
  • Respiratory
Locations
  • FDF Manufacturing Facility, New Jersey, New Jersey, USA
  • Headquarters, Sant Cugat del Vallès, Catalonia, Spain
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.